This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
BG Group (BG.L) – Royal Dutch Shell said its planned £55bn merger with BG Group cleared its last international regulatory hurdle as it received unconditional merger clearance from the Chinese Ministry of Commerce. Closing price 948p (Reuters)
AstraZeneca (AZN.L) - British drugmaker AstraZeneca Plc is in advanced talks to buy privately held cancer drug developer Acerta Pharma BV for more than $5 billion, the Wall Street Journal reported. Closing price 4330p (Reuters)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| Int. Consolidated Airlines | IAG | -1.13% | 0.61% | -1.22% |
| AstraZeneca | AZN | -1.13% | 0.48% | -1.24% |
| Bellway | BWY | 4.05% | 5.53% | 2.22% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research